MicroVention Terumo is a medical device company. It develops catheter-based and minimally-invasive neuroendovascular technologies for cerebral aneurysms and other neurovascular diseases. The company’s products include delivery and detachment systems, access products, intraluminal devices, occlusion balloons, and flow diverters, as well as polymer, platinum, and hydrogel coil products. MicroVention Terumo offers its products through a network of specialty distributors primarily in North America, South America, Europe, Africa, the Middle East, and Asia Pacific. Founded in 1997, MicroVention Terumo is based in Tustin, California. As of March 30, 2006, it operates as a subsidiary of Terumo Corporation.

Penumbra, Inc. develops clinically beneficial products that help patients suffering from stroke and other neurovascular diseases. It offers Penumbra System, an ischemic stroke device platform; Penumbra Coil 400 that allows rapid packing of aneurysms; 5MAX ACE, a clot extraction device for engaging and removing blood clots causing an acute ischemic stroke; and Neuron System, a family of access catheters to enable therapies to be delivered to blood vessels high up in the brain. The company sells its products in North and South America, Europe, Australia, and Asia. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.

Manufactures pharmaceuticals

CoAxiaTM was a development stage, private, venture-backed medical device company in clinical trials with an innovative, catheter-based therapy for the treatment of cerebral ischemia, most notably: ischemic stroke. CoAxia's business focus was demonstrating the safety and efficacy of its NeuroFlo™ catheter and making it a standard treatment option hundreds of thousands of stroke patients worldwide. In addition, CoAxia was in limited distribution of NeuroFlo to treat cerebral vasospasm, under an HDE market approval from the FDA. CoAxia holds several key patents on the concept and implementation of cerebral perfusion augmentation as well as numerous other patents relevant to various vascular disorders.\nCoAxia was founded in 1999 by Denise Barbut MD.

Sanofi A/S engages in the production of prescription drugs as well as participates in clinical trials of present and future products. It specializes in diabetes, oncology, multiple sclerosis, rare disease and cardio vascular illnesses. The company is headquartered in Copenhagen, Denmark.

MIVI Neuroscience focuses on the development and commercialization of clinical solutions for neurointerventional procedures. Their innovative product portfolio provides physicians with unique devices that improve patient outcomes by reducing complications, shortening procedure times, and expanding treatment to more patients. The company was founded in 2013 and is headquartered in Eden Prairie, Minnesota.

Stago is a pharmaceutical company with a strong interest in clinical pathology and in Haemostasis. Stago develops and markets automated systems for blood analysis in coagulation.

EKOS Corporation pioneered the development and the clinical application of ultrasound accelerated thrombolysis, introducing its first system for the treatment of vascular thrombosis in 2005. Today, interventional radiologists, cardiologists and vascular surgeons at leading institutions around the world use the EKOS EkoSonic Endovascular System to provide faster, safer and more complete dissolution of thrombus.

Zoll Circulation, Inc., a subsidiary of Asahi Kasei Corp., is an American company. The firm manufactures cardiac resuscitation devices.

Jinzhou Ahon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of medicine. Its products include calf serum deproteinized injection, penehyclidine hydrochloride injection, calf serum deproteinized enteric-coated capsules, glutamine granules, nervous system drugs, oncology drugs, perioperative drugs, and pediatric medicine. The company is headquartered in Jinzhou, China.

Cox & Company is an aerospace manufacturer of low-power ice protection systems, temperature control products, and electronic controllers.

Chengdu List Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese and western medicine raw materials. It also offers supplemental materials, intermediates, preparations, pharmaceutical products and equipment, biological products, health supplies, and medical packaging materials. Its business activities include product development, pharmaceutical technology development, installation and maintenance of pharmaceutical equipment, pharmaceutical engineering design, and technology consulting services. The company was founded on January 29, 2009 and is headquartered in Chengdu, China.

Since it was established in 1977, BALT has worked with neurovascular surgeons to treat complex life-threatening conditions such as strokes, aneurysms and arteriovenous malformations. A pioneer in its field, BALT designs, manufactures and distributes the ‘Interventional Neuro Radiology’ (‘INR’) devices such as catheters, stents and coils that are essential in treating such conditions. BALT is one of the leading pure play MedTech companies in Europe, and is a supplier to all major international hospitals practicing neuroradiology surgery. Headquartered in France, it boasts a number of proprietary, patent-protected products focusing on minimally invasive neurovascular techniques

Beijing Yimai Technology Co., Ltd., established on 2016-08-16, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Computer System Services;Application software service;Basic software service;design,make,acting,Place an ad;data processing(Bank Card Center in Data Processing,PUEvalue in1.5Except for the above cloud computing data centers);Repair instrumentation,office equipment;selling computers,Software and Auxiliary Equipment,electronic product,communication equipment,Equipment,electronic product,plastic products,crafts,First,two,Class III Medical Devices;Import and export,Technology Import and Export,Agent import and export;Conference Services;buisness planning;Undertake exhibition and display activities;Health Advisory(Except for medical treatment activities subject to approval);medical diagnosis,Monitoring and treatment equipment manufacturing;the medical,Manufacturing of surgical and veterinary instruments;Manufacture of Mechanical Therapy and Ward Nursing Equipment;Manufacturing of rehabilitation aids;Production and assembly of medical devices(Smart equipment for medical rehabilitation);publication retail;Internet information service;Production of Class II Medical Devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Production and assembly of medical devices(Smart equipment for medical rehabilitation),publication retail,Internet information service,Production of Class II medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

Sankyo Co., Ltd. engages in the manufacture and sale of pachinko and pachislot machines. It operates through the following segments: Pachinko Machines Business, Pachislot Machines Business, Ball Bearing Supply Systems Business, and Others. The Pachinko Machines Business segment produces and sells pachinko machines, machine gauges and its related parts. The Pachislot Machines Business segment markets pachislot machines and related parts. The Ball Bearing Supply Systems segment sells pachinko and pachislot ball feeders, card system equipment, and parlor-related equipment. The Others segment comprises of mobile content service, real estate, golf club operations, and sells general molding products. The company was established on April 12, 1966 and is headquartered in Tokyo, Japan.

Part of OMRON Corp., Omron Healthcare Co. Ltd. is a Japanese company located in Muko-shi that manufactures medical devices for health monitoring and treatment such as blood pressure monitors, digital thermometers, nebulizers & inhalers. The firm was founded in 1996. Isao Ogino is currently the CEO of the company.\nThe company says this about itself: Committed to improving people's lives, OMRON Healthcare provides clinically proven, innovative medical equipment for health monitoring and therapy. Our product portfolio includes blood pressure monitors, nebulizers, electronic thermometers, transcutaneous electronic nerve stimulators (TENS) as well as body composition monitors and professional medical devices. For many decades, OMRON's devices have helped people prevent, treat and manage lifestyle diseases both at home and in clinical practice in more than 100 countries in the world. OMRON HEALTHCARE Group is headquartered in Muko City, Kyoto Prefecture, Japan.

Boston Scientific Scimed, Inc. develops, manufactures, and markets medical devices used principally to treat cardiovascular disease.

AGA Medical Corp. manufactures medical devices used to treat structural heart defects and abnormal blood vessels. Its AMPLATZER products help improve patient outcomes, reduce length of hospital stay, and accelerate patient recovery times. The company was founded by Kurt Amplatz and Franck L. Gougeon on July 12, 1995 and is headquartered in Plymouth, MN.